Rupam Manna/LinkedIn
Jul 19, 2026, 16:59
Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on X:
“Not all portal vein involvement in HCC is the same.
The Vp classification helps define the extent of portal vein tumor thrombosis (PVTT) – one of the most important factors influencing prognosis and treatment strategy in hepatocellular carcinoma.
- Vp0–Vp2: Early vascular involvement where selected patients may still benefit from surgery or locoregional therapies.
- Vp3–Vp4: Major portal vein invasion, usually requiring systemic therapy, with Y-90 radioembolization (TARE) emerging as an important option in carefully selected patients.
Understanding the anatomy of portal vein invasion is key to making the right therapeutic decision.
Save this infographic for a quick review and share it with colleagues interested in liver cancer.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH